Nightly home hemodialysis: Outcome and factors associated with survival

Hemodialysis International

Volumn 15, Issue 2, 2011, Pages 211-218

  Lockridge, Robert S ^a,b   Kjellstrand, Carl M ^c,d,e  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Lynchburg Nephrology Dialysis Inc   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dialysis hours; Education; Nightly home hemodialysis; Survival

Indexed keywords

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; DIALYSIS; DISEASE COURSE; EDUCATION; FEMALE; HOME DIALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGHTLY HOME HEMODIALYSIS; OUTCOME ASSESSMENT; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; FEMALE; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954592029     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00542.x     Document Type: Article

References (41)

1. US Renal Data System (USRDS). 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
2. Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol. 1998; 9:859-868.
3. Dawson B, Trapp RG. Analyzing research questions about survival (Chapter 9). In: Dawson B, Trapp RG, eds. Basic and Clinical Biostatistics. 3rd ed. New York: Lange Medical Books; 2001:211-232.
4. US Renal Data System (USRDS). 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Section I. Patient Survival. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005:575-652.
5. Wolfe RA, Gaylin DS, Port FK, Held PJ, Wood CL. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int. 1992; 42:991-999.
6. Wolfe RA. The standardized mortality ratio revisited: Improvements, innovations and limitations. Am J Kidney Dis. 1994; 24:290-297.
7. Daugirdas JT, Kjellstrand CM. Chronic haemodialysis prescription: A urea kinetic approach. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis. Lippincott, Williams and Wilkins: Philadelphia; 2001:121-147.
8. Leypoldt J., Jaber BL, Zimmerman DL. Calculation of standard Kt/V (stdKt/V) with corrections for post-dialysis urea rebound. Hemodial Int. 2003; 7:73-104.
9. Garg PP, Diener-West M, Powe NR. Income-based disparities in outcomes for patients with chronic kidney disease. Semin Nephrol. 2001; 21:377-385.
10. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007; 99:1384-1394.
11. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: A review of the literature. Circulation. 1993; 88:1973-1998.
12. Kjellstrand C, Buoncristiani U, Sibai-Galland R, et al. Survival in short daily hemodialysis: Association of time, site and dose of dialysis. Hemodial Int. 2010; 14:464-470.
13. Kjellstrand C, Ing T, Kjellstrand P, Odar-Cederlof I, Blagg CR. Phosphorous dynamics during hemodialysis. Hemodial Int. 2011; 15 (in press).
14. Kjellstrand CM, Kjellstrand P, Odar-Cederlof I, Blagg CR, Ing TS. Studies of beta-2 microglobulin (B-2-dynamics during hemodialysis) (abstract). Hemodial Int. 2006; 10:127.
15. Pauly RP, Gill JS, Rose CL, et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant. 2009; 24:2915-2919.
16. Australian-New Zealand Dialysis and Transplant Registry. Available from: (accessed date: February 6, 2010).
17. Kjellstrand C, Buoncristiani U, Ting G, et al. Short daily hemodialysis: Survival in 415 patients treated by for 1006 patient years. Nephrol Dial Transplant. 2008; 23:3283-3289.
18. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 34:1725-1730.
19. Woods J, Port F, Stannard D, Blagg C, Held P. Comparison of mortality with home haemodialysis and center haemodialysis: A national study. Kidney Int. 1996; 49:1464-1470.
20. McGregor D, Buttimore A, Robson R, Little P, Morton J, Lynn K. Thirty years of universal home dialysis in christchurch. N Z Med J. 2000; 113:27-29.
21. Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von Hartitzsch B, Buselmeier TJ. The "unphysiology" of dialysis: A major cause of dialysis side effects? Kidney Int. 1975; 7:S30-S34.
22. Williams AW, Chebrolu S, Ing TS, et al. Early clinical quality of life and biochemical changes of "daily hemodialysis". Am J Kidney Dis. 2004; 43:90-102.
23. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in haemodialysis patients. Kidney Int. 1999; 55:1553-1559.
24. Karnik JA, Young BS, Lew NL, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int. 2001; 60:350-357.
25. Woods J, Friedrich K, Port M, et al. Clinical and biochemical correlates of starting 'daily' haemodialysis. Kidney Int. 1999; 55:2467-2476.
26. Ting GO, Freitas T, Kjellstrand C, Zarghamee S, Carrie BJ. Five-year comparison of conventional versus short daily hemodialysis in high-comorbidity end stage renal disease patients. Am J Kidney Dis. 2003; 42:1020-1035.
27. Silverburg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989; 36:286.
28. Fagugli RM, Reboldio G, Quintaliani G, et al. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients on daily. Am J Kidney Dis. 2001; 38:371-376.
29. Traeger J, Galland R, Delawari E, Arkouche W, Hadden R. Six years' experience with short daily haemodialysis: Do the early improvements persist in the mid and long term? Hemodial Int. 2004; 8:151-158.
30. Odar-Cederlof I, Bjellerup P, Williams A, et al. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodial Int. 2006; 10:394-398.
31. Chan C, Jain V, Pierratos A, Floras J. Nocturnal haemodialysis increases arterial baroreflex sensititvity and compliance and normalizes blood pressure of hypertensive patients with endstage renal disease. Kidney Int. 2005; 68:338-344.
32. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Alan S, Shuko L. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol. 2005; 16:2778-2788.
33. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA. 2007; 298:1291-1299.
34. Mahmoud B, Abdulkader A, El-Sharkawy M, Kahlil H. Assessment of pulmonary functions in chronic renal failure patients with different haemodialysis regimens. J Egypt Soc Parasitol. 2004; 34:1026-1040.
35. Spanner E, Suri R, Heidenheim PA, Lindsay RM. The Impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003; 42 (Suppl 1):S30-S35.
36. Pinciaroli AR. Hormonal changes in daily hemodialysis. Semin Dial. 1999; 12:455-461.
37. Mohr P, Neumann P, Franco S, Marainen J, Lockridge R, Ting G. The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis. 2001; 37:777-789.
38. Heidenheim PA, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl 1):S36-S41.
39. Komenda P, Copland M, Er L, Djurdjev O, Levin A. Outcomes of a provincial home haemodialysis programme-A two-year experience: Establishing benchmarks for programme evaluation. Nephrol Dial Transplant. 2008; 23:2647-2652.
40. Kliger AS. More intensive hemodialysis. Clin J Am Soc Nephrol. 2009; 4:S121-S214.
41. FHN Trial Group. In center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363:2287-2300.